FDA Approves New Therapy for Patients with Previously Treated Multiple Myeloma - FDA Press Releases

FDA approved Sarclisa (isatuximab-irfc), in combination with pomalidomide and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor

from FDA Press Releases RSS Feed https://ift.tt/2IbHZv5
via IFTTT